Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Switching Between Intravenous and Oral P2Y12 Inhibition: Easier Said Than Done.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Switching Between Intravenous and Oral P2Y12 Inhibition: Easier Said Than Done.
Switching Between Intravenous and Oral P2Y12 Inhibition: Easier Said Than Done. JACC Cardiovasc Interv. 2023 01 09; 16(1):47-49.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Adenosine Monophosphate
Administration, Intravenous
Humans
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Receptors, Purinergic P2Y12
Treatment Outcome
authors with profiles
Usman Baber